Remove Conditions Remove Epilepsy Remove Food Remove Patients
article thumbnail

Epilepsy and MMJ: Exploring the Promising Treatment Benefits

MMJ Recs

Epilepsy is a complex neurological disorder that affects millions of people worldwide, causing recurrent seizures that can significantly impact the quality of life. While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients.

Epilepsy 105
article thumbnail

Exploring New York’s MMJ Strains and Products

MMJ Recs

As the state’s medical cannabis program continues to evolve, patients are presented with a diverse array of MMJ strains and products to explore. Additionally, we’ll take a look at patient reviews of MMJ strains, offering valuable insights into the experiences of those utilizing medical cannabis in New York.

Strains 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Full List Of Qualifying Conditions for Medical Marijuana in Florida

LifeCannMD

On January 3, 2017, Amendment 2 came into effect in Florida allowing for the legal medicinal use of cannabis.The rules for use and administration are outlined in Senate Bill 8A of The Florida Medical Marijuana Legalization Initiative which allows for treatment of “diagnosable, debilitating conditions.” Learn more here. Learn more here.

article thumbnail

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures

LifeCannMD

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures Medical Marijuana has garnered significant attention for its benefits in treating epilepsy and seizures. The most compelling evidence of the effectiveness of Medical Marijuana in treating epilepsy comes from clinical trials.

article thumbnail

FDA Expands Epidiolex Access for Those with Tuberous Sclerosis Complex

Veriheal

A lack of federal legalization also makes it more difficult for the Food and Drug Administration (FDA) to approve cannabis-based products. Though Dravet Syndrome typically manifests itself in the first year of life, Epidiolex is only approved for treating patients two years of age and older. .

Access 98
article thumbnail

A Deep Dive into the Endocannabinoid System: The Science Behind Medical Marijuana

United Patients Group

The therapeutic potential of medical marijuana is gaining global recognition, with more and more people considering it as a plausible treatment option for a wide range of health conditions. The United Patients Group is committed to offering readers comprehensive, reliable insights into the use of medical marijuana.

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)